Clare Woodford/LinkedIn
Apr 2, 2026, 13:51
Clare Woodford: New NHS Access to Semaglutide Offers Hope to Prevent Another Stroke or Heart Attack
Clare Woodford, Head of Policy and Influencing at The Stroke Association, shared on LinkedIn:
”NICE‘s announcement that people who’ve had a stroke or heart attack and are overweight can access semaglutide on the NHS is an important development in tackling stroke and cardiovascular disease.
1 in 4 stroke survivors go on to have another stroke so this could be another vital resource in the toolbox to prevent more strokes.
Our website has more on stroke and weight loss, and steps to maintain a healthy weight.”

Stay updated with Hemostasis Today.
-
Nov 20, 2026, 13:20Ilenia Calcaterra: The Inferior Thyroid Arteries as a Window Into Cardiovascular Risk
-
Nov 20, 2026, 13:03Does Being Fit Protect Against VTE? – RPTH Journal
-
Nov 20, 2026, 12:29Thirunavukkarasu Angappan: Antithrombin in ECMO – Two Datasets, Two Opposite Answers
-
Nov 20, 2026, 11:38Muhammad Kashif: Therapeutic Plasma Exchange – Key Concepts at a Glance
-
Nov 20, 2026, 11:33Tyler McConville: Why Hemostatic Function Matters More Than Cell Counts in Trauma and Transfusion
-
Nov 20, 2026, 11:28Stéphanie Forté: Bringing Cutting-Edge Genomic and Proteomic Tools to Sickle Cell Disease Patients
-
Nov 20, 2026, 11:19EHC Urges Equal Early Diagnosis for Bleeding Disorders
-
Nov 20, 2026, 11:14Pushpinder Singh: How Do We Know if Haemodialysis is Effective?
-
Nov 20, 2026, 11:09Neel Patel: Honoured to Serve Across Five Faculty Roles at Hematocon 2026